On this photograph, an adult specimen of the ctenophore Mnemiopsis leidyi is seen from above. In the center of the image, it is possible to distinguish the aboral organ, a complex sensory structure.

Firmware TPM delivers robust, industrial-grade security for the Synaptics® Astra™ SL2610 product line, eliminating the ...

Neuroscientists at King’s College London (UK) have pinpointed a mechanism behind the increased neural connectivity seen in very early stages of Alzheimer’s disease. Published in Translational ...

BioArctic's AB (publ) (STOCKHOLM: BIOA B) partner Eisai announced today that they will present the latest findings on lecanemab at the 2026 International Conference on Alzheimer's and Parkinson's ...

A study reveals COVID-19 reshaped stimulant prescribing patterns in Ontario, highlighting increased ADHD diagnoses and concerns over treatment appropriateness.

A comprehensive invited review published today in Brain Medicine confronts one of the most persistent paradoxes in modern medicine: psychiatry remains the only major clinical discipline that diagnoses ...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today the company will present the latest findings on lecanemab (generic name, U.S. brand name: LEQEMBI®), Eisai's ...

Google Research and Synaptics have jointly announced a new limited‑edition Coral Dev Board aimed at developers building multimodal Edge AI applications. The board is powered by Synaptics’ Astra SL2610 ...